Algen Biotechnologies vs Isomorphic Labs
Side-by-side comparison of features, pricing, and ratings
At a glance
| Dimension | Algen Biotechnologies | Isomorphic Labs |
|---|---|---|
| Pricing | Contact (enterprise partnerships, e.g., $555M AstraZeneca deal) | Contact (pharma partnerships; $600M investment round in 2025) |
| Core Technology | AlgenCRISPR gene modulation + AlgenBrain AI (deep learning on gene expression) | AlphaFold + Drug Design Engine (predictive & generative AI for molecules) |
| Key Partnerships | AstraZeneca (2025, $555M immunology deal) | Novartis, Johnson & Johnson (2026 collaboration) |
| Best For | Target discovery via CRISPR gene modulation in cancer & inflammation | Lead optimization & molecule design for large pharma programs |
| Latest News | 2025-10-06: $555M AstraZeneca immunology partnership | 2026-05-12: Series B closed; 2026-01-20: J&J collaboration |
| Not For | Small labs without advanced genomics infrastructure | Individual researchers or self-service users |
Algen Biotechnologies is ideal for target discovery using CRISPR-based gene modulation, backed by a $555M AstraZeneca deal. Isomorphic Labs excels in molecule design and optimization, powered by AlphaFold and partnerships with Novartis and J&J. Choose Algen for early-stage target identification in immunology/oncology; choose Isomorphic for late-stage drug design and lead optimization.
AI-driven CRISPR platform revealing causal disease-driving RNA pathways for immunology and oncology drug discovery
Visit Website
What real users say: Algen Biotechnologies vs Isomorphic Labs
Not marketing copy and not our opinion — a structured sweep of public discussion (reviews, forums, communities and video comments), showing what people praise and what they complain about for each tool.
Algen Biotechnologies
20 mentions across 1 sources · 30% positive — critical
YouTube
What users praise
- • Backed by Nobel Laureate Jennifer Doudna's lab, adding credibility.
- • $555M AstraZeneca partnership validates enterprise-grade trust.
- • AlgenCRISPR enables precise, next-generation gene modulation.
- • AlgenBrain processes billions of gene expression changes for targets.
What frustrates them
- • Unavailable to individual researchers or small labs.
- • No public pricing or self-serve option; partnership-only model.
- • Negative sentiment from public confusion with algae fuel.
- • Skepticism about real-world efficiency and commercial viability.
Researched Aug 2, 2026
Isomorphic Labs
48 mentions across 3 sources · 82% positive
Hacker News, YouTube, Lemmy
What users praise
- • Built on the Nobel-winning AlphaFold, giving it instant credibility in structural biology.
- • Drug Design Engine extends beyond structure to generative molecule design, promising novel chemistry.
- • Deep partnerships with Novartis and J&J, with potential billions in royalties.
- • Interdisciplinary team of top ML and drug discovery experts, ensuring depth of expertise.
What frustrates them
- • Not accessible to individual researchers or small biotech due to partnership model only.
- • Proprietary nature of parts of its tech limits community scrutiny and independent validation.
- • CASP16 results suggest AlphaFold 3-based models aren't always better than older methods for protein-ligand interactions.
- • No marketed drugs yet; outcomes remain uncertain with royalties tied to long timelines.
Researched Aug 18, 2026
Who should pick which
- Pharma R&D team targeting immunologyPick: Algen Biotechnologies
Algen's AI-driven CRISPR platform reverse engineers disease trajectory for causal target discovery in immunology, as validated by its $555M AstraZeneca partnership.
- Large pharma optimizing late-stage leadsPick: Isomorphic Labs
Isomorphic's Drug Design Engine with AlphaFold accelerates lead optimization and molecule design, backed by Novartis and J&J collaborations.
- Cancer research enterprisePick: Algen Biotechnologies
Algen's focus on cancer and inflammation, using single-cell gene modulation and causal biology, is directly suited for oncology target discovery.
- Biotech startup needing molecule designPick: Isomorphic Labs
Isomorphic's generative AI and predictive models enable rapid design of novel molecules, but only through large pharma partnerships; not for small startups.
Frequently Asked Questions
Algen Biotechnologies vs Isomorphic Labs: which should you choose?
Algen Biotechnologies is ideal for target discovery using CRISPR-based gene modulation, backed by a $555M AstraZeneca deal. Isomorphic Labs excels in molecule design and optimization, powered by AlphaFold and partnerships with Novartis and J&J. Choose Algen for early-stage target identification in immunology/oncology; choose Isomorphic for late-stage drug design and lead optimization.
Which tool is better for identifying new drug targets?
Algen Biotechnologies, with its AlgenBrain AI and CRISPR gene modulation, is specifically built for causal target discovery in immunology and oncology.
Which company has a stronger AI foundation?
Both use cutting-edge AI. Isomorphic benefits from DeepMind's AlphaFold (Nobel Prize-winning), while Algen uses proprietary deep learning on gene expression. The choice depends on application.
Can small biotechs use these tools?
No. Both require enterprise-level partnerships. Algen's platform demands advanced genomics infrastructure, and Isomorphic works only through large pharma collaborations.
What are the recent major partnerships?
Algen partnered with AstraZeneca in October 2025 for immunology (up to $555M). Isomorphic collaborated with Johnson & Johnson in January 2026 and has Novartis deals.
Do they offer software or APIs?
Neither offers self-service software or APIs. Access is through partnership agreements only.
Which company has more funding?
Isomorphic Labs raised $600M in external investment (2025) plus a Series B (2026). Algen's disclosed funding is the $555M AstraZeneca partnership.
Are these tools applicable to rare diseases?
Algen's focus on causal biology could be applied to rare diseases with genetic underpinnings. Isomorphic's molecule design could be used for any disease, but only through partnerships.
Which is more mature?
Isomorphic Labs leverages mature AlphaFold technology and has secured multiple pharma collaborations. Algen is newer but validated by a major pharma deal.
More Algen Biotechnologies or Isomorphic Labs comparisons
Angle and Isomorphic Labs serve completely different domains—Angle is a free, niche pose-measurement tool for fitness professionals, while Isomorphic Labs is an enterprise AI drug discovery platform f
These tools are polar opposites in audience and purpose. Ironclaw AI Vision is a free, offline-first PWA for individual fitness tracking with AI coaching and meal planning – ideal for privacy-consciou
Choose Ray if you need an adaptive, low-barrier AI personal trainer for flexible, voice-guided workouts — it's ideal for busy individuals wanting consistency without gym intimidation. Choose Isomorphi
MediSphere and Isomorphic Labs serve completely different healthcare verticals. Choose MediSphere if you run a small clinic needing AI-powered administration, no-show prediction, and EHR. Choose Isomo
These tools serve completely different markets. CalBye is a consumer nutrition app for individuals wanting effortless calorie tracking via photos, while Isomorphic Labs is an enterprise drug discovery
Isomorphic Labs and Swimio serve completely different worlds: one is a high-stakes pharma AI platform for billion-dollar drug programs, the other a consumer fitness app for swimmers. Choose based on y
Explore each tool further
Browse these categories
One email a week — new tools, honest comparisons, no spam.
Last reviewed: July 3, 2026